Cancer Research
Studies from Osaka City University School of Medicine Yield New Data on Cancer Research
Published in Biotech Week, November 16th, 2011
2011 NOV 16 -- A new study, "New therapeutic strategies for castration-resistant prostate cancer," is now available. "Docetaxel has until recently been the only agent with a small survival benefit for metastatic castration-resistant prostate cancer (CRPC). To improve clinical outcome in CRPC, numerous classes of drugs targeting specific pathways involved in hormone action, bone metabolism, angiogenesis, apoptosis and immune response have currently been investigated concerning the efficacies of either single agents or combinations with docetaxel," scientists in Osaka, Japan report.
"Noteworthy, current two phase III trials of cabazitaxel and sipuleucel-T...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
Source: Biotech Week (2011-11-16)
More Articles from Biotech Week
- Nanomedicine
Arrowhead Research Appoints Brendan P. Rae, Ph.D., J.D., Chief Business Officer - Hepatitis C Virus
Biotica nominates drug candidate, BC556, a cyclophilin inhibitor to treat Hepatitis C - Brunswick Group
Brunswick Expands in China - Chronic Lymphocytic Leukemia
Data from Isfahan University of Technology Provide New Insights into Chronic Lymphocytic Leukemia - Biomedical and Dental Materials
Data from Spanish National Research Council (CSIC) Provide New Insights into Biomedical and Dental Materials - Applied Bioinformatics
Data from University of Victoria Advance Knowledge in Applied Bioinformatics - More from this issue of Biotech Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
